CA3233691A1 — Compositions and methods for treating sialorrhea
Assigned to University of Utah Research Foundation Inc · Expires 2023-05-04 · 3y expired
What this patent protects
The disclosure relates to methods and compositions comprising atropine and a carbomer 974P polymer and a non-cariogenic sweetener in a gel formulation wherein the formulation has a dissolution rate of 1 to 6 hours and wherein the atropine is present in an amount up to about 0.1 %…
USPTO Abstract
The disclosure relates to methods and compositions comprising atropine and a carbomer 974P polymer and a non-cariogenic sweetener in a gel formulation wherein the formulation has a dissolution rate of 1 to 6 hours and wherein the atropine is present in an amount up to about 0.1 % by weight for decreasing saliva production and treating sialorrhea.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.